Clinical Trial Update: Clinical Trial of Pramipexole in Bipolar Depression [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating pramipexole for bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Mirapex (pramipexole)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED